|
Stories from the dialysis comunity across the globe.
|
|
Affymax Reports Phase 2 Sub-Analysis Of Hematide™ In Hemodialysis Patients (Medical News Today) |
 |
 |
|
Affymax, Inc. (Nasdaq:AFFY) announced data from a post hoc sub-analysis of the Phase 2 clinical trial evaluation of Hematide in chronic renal failure patients undergoing dialysis. read more |
|
|
Mercy celebrates ‘second home’s’ fifth birthday (Scoop.co.nz) |
|
|
|
Auckland resident Mercy Tangimai is just one of 38 clients who have benefitted from the home comforts of the Kidney Society-owned Dialysis House in Papatoetoe, and he’ll be back this week to help the society celebrate the House’s fifth birthday. read more |
|
Assessing Biosimilars In Practice: Considerations For The Hospital Pharmacist To Evaluate (Medical News Today) |
|
|
|
Hospira (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today sponsored a satellite symposium at the European Association of Hospital Pharmacists (EAHP) congress. The symposium focussed on the information a pharmacist may need to consider when evaluating a biopharmaceutical for inclusion in a hospital formulary. read more |
|
|
Dialysis unit unveiled (The Sudbury Star) |
|
|
|
Eva Sarre of Sudbury isn't a woman to feel sorry for herself. Some people diagnosed with kidney failure might regard hospital hemodialysis as a death sentence. Not Sarre.[...] read more |
|
Compugen Announces Positive Therapeutic Effects Of Relaxin Receptor Peptide Ligand In Pulmonary Fibrosis Animal Model (Medical News Today) |
|
|
|
Compugen (NASDAQ:CGEN) announced that CGEN-25009, a novel peptide that previously demonstrated the ability to activate the Relaxin receptor LGR7 (RXFP1) in cell based assays, has shown positive therapeutic effects in an animal model of pulmonary fibrosis. read more |
|
|
|
|
<< Start < Prev 3701 3702 3703 3704 3705 3706 3707 3708 3709 3710 Next > End >>
|
|
Page 3705 of 4210 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
